Recent Finacing
Recent Raise
The company develops antibody–oligonucleotide conjugates to deliver therapeutic oligonucleotides to skeletal muscle cells to restore function in muscular dystrophy.
Focus Areas
Total Raised
Funding round
See the team members at Nido.
